4CPS-018 Evaluation of antiplatelet agent prescribing in patients on direct oral anticoagulant

BackgroundAmong patients requiring an oral anticoagulant (OAC), a large proportion also take an antiplatelet agent (AP). Several studies have highlighted the significantly increased bleeding risk associated with a combined OAC (VKA mainly) and AP (aspirin mainly) therapy, without a reduction in risk...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2019-03, Vol.26 (Suppl 1), p.A75-A76
Hauptverfasser:	Larock, AS, Spinewine, A, Laloux, P, Eucher, P, Hanet, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Cardiovascular disease Coronary vessels Pharmacists Thromboembolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!